|
Source (N° of cases)
|
Disease
|
HCT
|
PTLD (days)
|
PTLD (type)
|
|---|
|
Young 1989[6] (2)
|
T cell LL
|
T cell purged
|
48/31
|
NHL polymorphic B cell
|
|
Chao 1993[7] (1)
|
FML
|
B cell purged
|
52
|
NHL monomorphic B cell
|
|
Shephered 1995[8] (1)
|
CML
|
Unmanipulated
|
43
|
NHL polymorphic B cell
|
|
Briz 1997[9] (1)
|
T cell ALL
|
T cell purged
|
81
|
NHL monomorphic B cell
|
|
Hauke 1998[10] (2)
|
HD/FLL
|
Unmanipulated
|
87/38
|
NHL polymorphic B cell
|
|
Peniket 1998[11] (1)
|
MM
|
CD34+ selected
|
80
|
NHL monomorphic B cell
|
|
Lohrish 2000 [12] (1)
|
BL
|
Unmanipulated
|
39
|
NHL polymorphic B cell
|
|
Yufu 2000 [13] (1)
|
HD
|
Unmanipulated
|
900
|
T cell PTLD
|
|
Jenkins 2002 [14] (3)
|
2MM/1NHL
|
CD34+ selected/Unmanipulated
|
31/NA
|
NHL polymorphic B cell
|
- ALL: acute lymphoblastic leukemia; CML: chronic myelogenous leukemia; FML: follicular mixed small cleaved and large lymphoma; FLL: follicular large cell lymphoma; LCL: large cell lymphoma; LL: lymphoblastic lymphoma; BL: Burkitt's lymphoma; HD: hodgkin disease; NHL: non hodgkin lymphoma; MM: multiple myeloma PTLD: post transplant lymphoproliferative disorder; HCT: hematopoietic cell transplantation; NA: not available.
